Hot Features
Premium
Level up your trading with our powerful tools and real-time insights all in one place.
Period:
Draw Mode:
| Volume | 736 |
|
|||||
| News | - | ||||||
| Day High | 10.10 | Low High |
|||||
| Day Low | 9.85 | ||||||
| Share Name | Share Symbol | Market | Stock Type |
|---|---|---|---|
| Surrozen Inc | SRZN | NASDAQ | Common Stock |
| Price Change | Price Change % | Share Price | Last Trade
|
|
|---|---|---|---|---|
| -0.0999 | -0.99% | 10.00 | 16:16:11 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 10.10 | 9.85 | 10.10 | 10.00 | 10.0999 |
| Trades | Shares Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 65 | 736 | US$ 10.06 | US$ 7,405 | - | 4.50 - 16.19 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 15:00:00 | 2 | US$ 9.61 | USD |
Surrozen Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 20.38M | 2.04M | - | 0 | -43.04M | -21.12 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Surrozen News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/03/2024 | 07:40 | GlobeNewswire Inc. | Surrozen Publishes Study in 'Respiratory Research'.. |
| 4/01/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Announces Safety, Pharmacodynamic and Liver.. |
| 4/01/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Announces up to $192.5 Million Private Placement of.. |
| 2/07/2024 | 05:16 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 2/07/2024 | 05:10 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/22/2024 | 16:24 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 1/18/2024 | 07:41 | Edgar (US Regulatory) | Form 8-K - Current report |
| 1/18/2024 | 07:30 | GlobeNewswire Inc. | Surrozen Provides Corporate Update on Clinical Programs |
| 12/18/2023 | 20:26 | Edgar (US Regulatory) | Form 4 - Statement of changes in beneficial ownership of.. |
| 12/13/2023 | 16:21 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
| 12/13/2023 | 16:14 | Edgar (US Regulatory) | Form 8-K - Current report |
| 12/11/2023 | 15:11 | Edgar (US Regulatory) | Form 424B3 - Prospectus [Rule 424(b)(3)] |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical SRZN Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 8.14 | 11.00 | 8.14 | 9.91 | 10,737 | 1.86 | 22.85% |
| 1 Month | 10.86 | 11.825 | 8.14 | 10.22 | 13,311 | -0.86 | -7.92% |
| 3 Months | 9.19 | 16.19 | 8.14 | 11.21 | 17,869 | 0.81 | 8.81% |
| 6 Months | 6.5235 | 16.19 | 4.50 | 7.82 | 40,431 | 3.48 | 53.29% |
| 1 Year | 9.795 | 16.19 | 4.50 | 8.56 | 72,270 | 0.205 | 2.09% |
| 3 Years | 143.25 | 210.00 | 4.50 | 31.14 | 180,330 | -133.25 | -93.02% |
| 5 Years | 143.25 | 210.00 | 4.50 | 31.14 | 180,330 | -133.25 | -93.02% |
Surrozen Description
| Surrozen Inc is a class of therapeutics to treat serious diseases characterized by tissue injury. Its product candidate includes SZN-1326 (Fzd5/Lrp6, SWAP), and SZN-043 (E3/ASGR1, SWEETS). |
